Skip to content

Author

T. Bagci-Onder

We have 3 of 87 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

BRD9 inhibition induces selective radiosensitivity in glioblastoma through MYC pathway modulation

Radiotherapy (RT) is a cornerstone of glioblastoma (GBM) treatment, yet therapeutic resistance remains nearly universal due to the rapid activation of stress-adaptive survival programs. Identifying molecular regulators that sustain these adaptive responses may reveal context-dependent vulnerabilities that can be therap...

Nareg Degirmenci, S. A. Celikkol, B. N. Koseoglu et al. · 0 citations
Open access Sep 2026

DDRKOL: A Focused CRISPR Library for Systematic Identification of DNA Damage Response Dependencies in Glioblastoma

DDRKOL represents a robust and versatile focused CRISPR platform for systematic functional interrogation of the DDR associated genes and can be broadly applied across diverse biological contexts to discover context-dependent DDR vulnerabilities, therapeutic targets, and mechanisms of treatment resistance.

Canan Bayraktar-Odabas, I. Kok, Altar Ozbiyik et al. · 0 citations
Jul 2026

Epigenome-Wide CRISPR-Cas9-Based Knockout Screens on Chemoresistant Cells.

Key methodological steps for achieving high-efficiency lentiviral transduction and selection are described, enabling the successful application of EPIKOL CRISPR screens in chemoresistant TNBC models.

O. Yedier-Bayram, Elif Ayca Guvener, T. Bagci-Onder · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.